cancer immunotherapy
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.
CellVec enters strategic partnership with Peter MacCallum Cancer Centre
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.
Most Read
1. Singapore’s AI tool analyses heart attack damage within one minute 2. How can Asia-Pacific prove medical research is worth the money? 3. Medical Taiwan 2026 closes with $168.7m in business opportunities 4. China's healthcare sector set for global breakout 5. Obesity drains $45b annually from Australia’s economyResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential